D
N+ Score64
Longevity & NAD+Serving: 1 Capsule(s)Type: Other Combinations

Cardiovascular Research Quercetin-C is a longevity and NAD+ category supplement formulated with Quercetin, Rutin, Vitamin C, and Phosphatidylcholine. Each capsule delivers 100 mg of Quercetin, 250 mg of Rutin, 100 mg of Vitamin C, and 250 mcg of Phosphatidylcholine. Both Vitamin C and Phosphatidylcholine are present at clinically studied doses in this 4-ingredient formula. The product holds an N+ Score of 64, earning a 'D' grade, indicating an average performance in Nutrienting's evaluation. While label transparency is excellent at 100%, its ingredient adequacy and formula completeness are rated at 50% and 25% respectively. This supplement may appeal to individuals seeking targeted support for cellular health and antioxidant benefits.

About This Product

Quercetin-C by Cardiovascular Research is a longevity & nad+ supplement containing 4 active ingredients. It has earned an N+ Score of 64/100 (Grade D).

Notable clinical-dose ingredients include Vitamin C, Phosphatidylcholine.

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +2 ingredient(s) at clinical dose levels

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (4 ingredients)

IngredientAmountDose Adequacy
Vitamin C100.000 mgAdequate
Quercetin100.000 mgN/A
Rutin250.000 mgN/A
Phosphatidylcholine250.000 mcgAdequate

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.